| | | | | |
CHRS Coherus Oncology, Inc. Common Stock | $1,3750 | -3,17% | $219,39M | $504,71K | |
| $2,7900 | +2,01% | $217,47M | $1,62K | |
MFM Aberdeen Municipal Income Fund | $5,2700 | -0,19% | $217,47M | $187,37K | |
CHCI Comstock Holding Companies, Inc. Class A | $20,8150 | -1,58% | $217,46M | $38,22K | |
PTAC Patriot Acquisition Corp. Class A Ordinary Shares | $10,0000 | +0,60% | $217,43M | $11,00 | |
ARMP Armata Pharmaceuticals, Inc. Common Stock | $5,8200 | -0,34% | $217,14M | $45,11K | |
EXFY Expensify, Inc. Class A Common Stock | $2,3800 | +0,00% | $217,02M | $417,55K | |
| $62,8400 | -3,05% | $216,79M | $18,29K | |
IIF Morgan Stanley India Investment Fund, Inc. | $22,8100 | -1,17% | $216,64M | $30,78K | |
VYGR Voyager Therapeutics, Inc. Common Stock | $3,3800 | -3,70% | $216,27M | $319,71K | |
MITT TPG Mortgage Investment Trust, Inc. | $6,7800 | -0,29% | $216,26M | $216,24K | |
| $1,5400 | -2,53% | $215,73M | $1,01M | |
PEPG PepGen Inc. Common Stock | $3,2000 | +2,89% | $215,39M | $1,89M | |
PLX Protalix BioTherapeutics, Inc. Common Stock | $2,6500 | -0,75% | $215,12M | $881,58K | |
GSHR Gesher Acquisition Corp. II Class A Ordinary Shares | $10,5100 | -0,10% | $214,97M | $50,17K | |
